In a significant development for patients battling chronic graft-versus-host disease (GVHD), the U.S. Food and Drug Administration (FDA) has granted approval to Niktimvo™ (axatilimab-csfr), a groundbreaking anti-CSF-1R antibody. This approval marks a pivotal moment in...
WILMINGTON, Del.--(BUSINESS WIRE)--Feb. 27, 2024-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for axatilimab, an anti-CSF-1R antibody, for the treatment...
This month’s call in program will focus on Multiple Myeloma featuring featuring Dr. C. Ola Landgren, M.D., PhD, Professor of Medicine, Chief of Myeloma Division, Director of the Sylvester Myeloma Institute. Dr. Landgren’s clinical interests include novel therapeutics,...
The National Bone Marrow Transplant Link, www.nbmtlink.org invites you to participate in a FREE webinar that will help you and your loved ones better understand Graft Versus Host Disease Thursday, Jan. 27, 20221:30 PM EST - Start time may vary by time zone To Register...
One of the key objectives of the Foundation is to provide funding for research to prevent, treat and cure Graft vs. Host Disease. In 2019, the Foundation provided a designated Grant through the Leukemia Lymphoma Society (LLS) to Dr. Ivan Maillard, MD, PHD. We are...
This month’s telephone educational and support program will help cancer survivors and their families better understand the COVID vaccine and the important need for booster shots
EVENT DATE AND TIME: Tuesday, Oct. 20, 2020 Noon to 1:30 pm EST Be sure to note the various time zone start times as indicated here: 12 pm (Noon): Eastern Time 11 am: Central Time 10 am: Mountain Time 9 am: Pacific Time Survivorship Issues Following a Bone Marrow/Stem...
The 2020 Graft vs Host Disease National Symposium will be a virtual symposium at no charge.
KEYNOTE SPEAKER: Joseph H. Antin, MD Dana Farber Cancer Insitute Dr. Antin received his MD from Cornell University in 1978, and postgraduate training in hematology and medical oncology at DFCI and Brigham and Women's Hospital. He subsequently served as director of the...